Stockreport

Kineta Announces Restructuring and Exploration of Strategic Alternatives

Kineta, Inc.  (KA) 
PDF SEATTLE, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in onc [Read more]